iBio, Inc. (IBIO) › Capital ExpendituresiBio, Inc. (IBIO) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $1.2K2012: $1.0K2013: $7.0K2014: $4.0K2015: $13.0K2016: $68.0K2017: $1.32M2018: $934.0K2019: $920.0K2020: $1.08M2021: $4.92M2022: $7.33M2023: $5.74M2024: $210.0K2025: $16.0K$16.0K2011Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$16.0K-92.4%2024$210.0K-96.3%2023$5.74M-21.7%2022$7.33M+49.0%2021$4.92M+356.4%2020$1.08M+17.2%2019$920.0K-1.5%2018$934.0K-29.4%2017$1.32M+1845.6%2016$68.0K+423.1%2015$13.0K+225.0%2014$4.0K-42.9%2013$7.0K+600.0%2012$1.0K-18.3%2011$1.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share